Dr. Moshe Levy
Claim this profileTexas Oncology - Baylor Charles A. Sammons Cancer Center
Area of expertise
Acute Myelogenous Leukemia
Moshe Levy has run 5 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Moshe Levy has run 4 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Baylor Scott White University Medical Center
Clinical Trials Moshe Levy is currently running
Iberdomide vs Lenalidomide
for Multiple Myeloma
This trial is testing two treatments, iberdomide and lenalidomide, to see which one is better at preventing cancer from coming back in patients with newly diagnosed multiple myeloma after a stem cell transplant. These treatments help the immune system fight off cancer cells. Lenalidomide has been used for the treatment of multiple myeloma, showing effectiveness and improving survival outcomes.
Recruiting
2 awards
Phase 3
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting
1 award
Phase 3
4 criteria
More about Moshe Levy
Clinical Trial Related
3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Moshe Levy has experience with
- Azacitidine
- Lenalidomide
- Rituximab
- Venetoclax
- Gilteritinib
- Lanraplenib
Breakdown of trials Moshe Levy has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Moshe Levy specialize in?
Moshe Levy focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 positive patients, or patients who are CD123 positive.
Is Moshe Levy currently recruiting for clinical trials?
Yes, Moshe Levy is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Moshe Levy has studied deeply?
Yes, Moshe Levy has studied treatments such as Azacitidine, Lenalidomide, Rituximab.
What is the best way to schedule an appointment with Moshe Levy?
Apply for one of the trials that Moshe Levy is conducting.
What is the office address of Moshe Levy?
The office of Moshe Levy is located at: Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology - Baylor Charles A. Sammons Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.